Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.000
+0.080 (2.04%)
At close: Sep 26, 2025, 4:00 PM EDT
3.970
-0.030 (-0.75%)
After-hours: Sep 26, 2025, 7:46 PM EDT
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$339
Profits / Employee
-$1,487,220
Market Cap
353.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALT News
- 4 days ago - Altimmune to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 6 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - GlobeNewsWire
- 8 days ago - Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune and SelectQuote that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - GlobeNewsWire
- 9 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 6, 2025 in Altimmune, Inc. Lawsuit - ALT - PRNewsWire
- 12 days ago - Altimmune Appoints Accomplished Commercial Executive Linda M. Richardson as Chief Commercial Officer - GlobeNewsWire
- 14 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - PRNewsWire
- 17 days ago - Altimmune, Inc. (ALT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Altimmune: Is There Still Hope For Pemvidutide? I Believe There Is (Upgrade) - Seeking Alpha